NCT04812509 2023-02-24
Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3 Completed
Clinical Trials
4 trialsNCT04550949 2020-09-22
To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT03550508 2018-06-08
JMT103
Shanghai JMT-Bio Inc.
Phase 1 Unknown
NCT01106352 2017-01-04
A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)
Bayer
Phase 1/2 Completed